Showing results (691-700 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|July 16, 2009
Current prodrug design for drug discoveryPei-Wen Hsieh, Chi-Feng Hung, Jia-You FangCurrent Pharmaceutical Design|July 16, 2009
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologiesGarrit Koller, Uwe Schlomann, Panagiota Golfi, et al.Current Pharmaceutical Design|July 16, 2009
ADAM17 as a therapeutic target in multiple diseasesJoaquín Arribas, Cary EsselensCurrent Pharmaceutical Design|July 16, 2009
ADAM28 as a target for human cancersSatsuki Mochizuki, Yasunori OkadaCurrent Pharmaceutical Design|July 16, 2009
Peptides targeting angiogenesis related growth factor receptorsLuca D D'Andrea, Annarita Del Gatto, Lucia De Rosa, et al.Current Pharmaceutical Design|July 16, 2009
Targeting rho GTPases by peptidic structuresFilippo Marchioni, Yi ZhengCurrent Pharmaceutical Design|July 16, 2009
Modulating proteostasis: peptidomimetic inhibitors and activators of protein foldingFeras Hatahet, Lloyd W RuddockCurrent Pharmaceutical Design|July 16, 2009
Cyclin dependent kinases as attractive targets to prevent transcription from viral genomesFatah Kashanchi, Kylene Kehn-HallCurrent Pharmaceutical Design|February 12, 2010
Towards high resolution optical imaging of beta cells in vivoM Villiger, J Goulley, E J Martin-Williams, et al.Current Pharmaceutical Design|February 12, 2010
Identification of new pancreatic beta cell targets for in vivo imaging by a systems biology approachThomas Bouckenooghe, Daisy Flamez, Fernanda Ortis, et al.Pageof 1,007